Visit LabLeaders.com to learn more about laboratory management.
Diagnosis of Group A streptococcal infection is a core function of primary care for most adults and children presenting with acute sore throat. While culture has the advantage of providing reference standard testing, it takes 1-2 days, leading to delays in care for the patient, and additional contacts between patient and clinician practices.
Nucleic acid amplification testing (NAAT) for Group A strep provides highly sensitive and specific diagnosis for this infection, exceeding even the accuracy of standard cultures. Some national guidelines have already shifted to support the use of NAAT over antigen based testing; others have not been updated to reflect current diagnostic techniques.
Join us for the next LabLeaders webinar to hear Matthew J. Thompson, MD, MPH, DPhil, share valuable information on diagnostic testing strategies for group A streptococcus. During this engaging session, you’ll learn about diagnostic options for point-of-care testing for group A strep, as well as antimicrobial prescribing stewardship efforts in primary care for respiratory tract infections. You’ll also gain valuable insights on current guidelines and recommendations for diagnostic testing for pharyngitis in adults and children in the U.S.
WHAT YOU WILL LEARN
- How to review evidence for current antimicrobial prescribing and stewardship efforts in primary care for respiratory tract infections
- The evidence for different diagnostic options for point of care testing for Group A strep
- Current guidelines and recommendations for use of diagnostic testing for pharyngitis in adults and children in the US
Matthew J. Thompson, MD, MPH, DPhil
Professor and Vice Chair for Research
Department of Family Medicine
University of Washington